NDC 73063-035

RELYVRIO

Sodium Phenylbutyrate/taurursodiol

RELYVRIO is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Amylyx Pharmaceuticals Inc. The primary component is Sodium Phenylbutyrate; Taurursodiol.

• Product ID: 73063-035_a9d047a0-e5f6-441b-89d5-994766d6afcb
• NDC: 73063-035
• Product Type: Human Prescription Drug
• Proprietary Name: RELYVRIO
• Generic Name: Sodium Phenylbutyrate/taurursodiol
• Dosage Form: Powder, For Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2022-09-29
• Marketing Category: NDA /
• Application Number: NDA216660
• Labeler Name: Amylyx Pharmaceuticals Inc
• Substance Name: SODIUM PHENYLBUTYRATE; TAURURSODIOL
• Active Ingredient Strength: 3 g/1; g/1
• Pharm Classes: Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 73063-035-03

56 POWDER, FOR SUSPENSION in 1 CARTON (73063-035-03)

• Marketing Start Date: 2022-09-29
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details